European Archives - Page 924 of 1164 - European Medical Journal

Continue
31 Oct 2017

Oh, Did We Mention We Were Finalists in October?

So, if you are reading this blog, you may or may not be aware that our social media is quite a fabulous place to find yourself… and that’s not just our…
31 Oct 2017

Introducing EMJ Diabetes 5.1

United Kingdom, October 31, 2017: EMJ would like to welcome you to the latest edition of EMJ Diabetes, a journal dedicated to detailing…
16 Mins
31 Oct 2017

Review of the 53rd European Association for the Study of Diabetes Congress 2017

Sunny Lisbon played host to this year’s European Association for the Study of Diabetes (EASD) 53rd Annual Meeting, welcoming 15,000 attendees…
8 Mins
31 Oct 2017

Session One: Basal Insulins: Still Innovating After All These Years

Advances in understanding diabetes pathophysiology and treatment permit individualised therapy based on patient-centred treatment plans.
October 2017

EMJ Diabetes 5.1 2017

EMJ would like to welcome you to the latest edition of EMJ Diabetes, a journal dedicated to detailing the vital progression in the treatment of diabetes…
1 Mins
31 Oct 2017

A Role for Connexin Mediated Cell Communication in Fibrosis of Tubular Epithelial Cells in the Diabetic Kidney

Diabetic nephropathy represents the leading cause of end-stage renal disease and is the greatest cause of patient entry into the renal replacement…
2 Mins
31 Oct 2017

Sex Differences in the Diabetes-Associated Risk of Cardiovascular Events in a Young Population

The diabetes-associated excess risk of cardiovascular diseases is known to be higher in women than in men. Find out more in the article
12 Mins
31 Oct 2017

Session Two: Changing the Type 2 Diabetes Mellitus Management Paradigm with Fixed-Ratio Combinations

Fixed-ratio combinations, the co-administration of two injectable therapies in a formulation that can be adjusted through titration, are changing the…
2 Mins
31 Oct 2017

Short-Term Renal Effects of Vildagliptin Addition and Their Clinical and Laboratory Predictors in Insulin-Treated Type 2 Diabetes Mellitus Patients: A Randomised, Comparative, Prospective Clinical Study

Positive renal effects of vildagliptin have been shown by several experimental studies.1,2 Nonetheless, clinical evidence for its renoprotective…
19 Mins
31 Oct 2017

Session Three: Innovating Beyond Glucose Control in Diabetes Care

Advances in treatment offerings are moving beyond classical considerations around glucose control to focus on other aspects of the disease.
We’ve noticed you’re accessing
from North/South America.